Compare Bitwise Crypto Industry Innovators ETF (BITQ) vs IDEXX Laboratories, Inc. (IDXX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bitwise Crypto Industry Innovators ETF vs IDEXX Laboratories, Inc. — how do they compare? Bitwise Crypto Industry Innovators ETF trades at $22.74, while IDEXX Laboratories, Inc. trades at $569.65 (market cap $46.22B). The key difference: Bitwise Crypto Industry Innovators ETF is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals.
| BITQ | IDXX | |
|---|---|---|
Sector | Crypto-linked | Health |
52-Week High | $30.43 | $766.68 |
52-Week Low | $16.74 | $526.44 |
Market Cap | — | $46.22B |
Enterprise Value | — | $47.12B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BITQ is trading at $22.74, up 2.48% today, but technical indicators show a bearish trend with 15 sell signals versus 1 buy signal. The stock faces resistance at $23-$24 while finding support at $22. Key moving averages remain bearish, though oscillators suggest neutral momentum. Financial ratios including P/E, P/S, and ROE are currently unavailable for analysis.
The outlook remains cautious given the bearish technical picture and lack of recent fundamental data. Investment opportunity depends on upcoming earnings clarity and institutional sentiment shifts. Primary risks include market volatility and potential competitive pressures in the company's sector.
IDEXX Laboratories (IDXX) trades at $570.58, down 4.23% over 24 hours, with a bullish technical signal and strong fundamentals. The stock has consistently beaten earnings estimates, with Q2 2026 EPS of $4.27 surpassing the $3.94 expectation. Revenue growth remains robust, supported by a 74.21% ROE and expanding diagnostic offerings. Recent news highlights product expansion, including a dual-species cardiac test, reinforcing its market leadership in veterinary diagnostics.
The outlook is positive, driven by durable competitive advantages and international growth potential. However, elevated valuation multiples and competitive pressures pose risks. Analyst consensus is bullish with a $683.33 price target, suggesting significant upside from current levels, though investors should monitor execution on guidance and macroeconomic headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bitwise Crypto Industry Innovators ETF
BITQ tracks companies at the forefront of the crypto economy, including miners, equipment suppliers, and financial service providers. It offers indirect exposure to the growth of the broader crypto ecosystem.
Read more on BITQ →About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →
